Search by Drug Name or NDC
NDC 75854-0312-30 PRENATE DHA 40; 90; 155; 400; 25; 300; 18; 1; 50; 26 [iU]/1; mg/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1 Details
PRENATE DHA 40; 90; 155; 400; 25; 300; 18; 1; 50; 26 [iU]/1; mg/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1
PRENATE DHA is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Avion Pharmaceuticals, LLC. The primary component is .ALPHA.-TOCOPHEROL, DL-; ASCORBIC ACID; CALCIUM FORMATE; CHOLECALCIFEROL; CYANOCOBALAMIN; DOCONEXENT; FERROUS ASPARTO GLYCINATE; FOLIC ACID; MAGNESIUM OXIDE; PYRIDOXINE HYDROCHLORIDE.
Product Information
NDC | 75854-0312 |
---|---|
Product ID | 75854-312_b8552bf1-132f-4720-e053-2a95a90af78b |
Associated GPIs | 78516025000125 |
GCN Sequence Number | 072472 |
GCN Sequence Number Description | prenatal 78/iron/folate 1/dha CAPSULE 18-1-300MG ORAL |
HIC3 | C6F |
HIC3 Description | PRENATAL VITAMIN PREPARATIONS |
GCN | 36696 |
HICL Sequence Number | 041203 |
HICL Sequence Number Description | PRENATAL VITAMINS NO.78/IRON ASPARTO GLYCIN/FOLATE NO.1/DHA |
Brand/Generic | Brand |
Proprietary Name | PRENATE DHA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, calcium formate, ferrous asparto glycinate, magnesium oxide and doconexent |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE, GELATIN COATED |
Route | ORAL |
Active Ingredient Strength | 40; 90; 155; 400; 25; 300; 18; 1; 50; 26 |
Active Ingredient Units | [iU]/1; mg/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
Substance Name | .ALPHA.-TOCOPHEROL, DL-; ASCORBIC ACID; CALCIUM FORMATE; CHOLECALCIFEROL; CYANOCOBALAMIN; DOCONEXENT; FERROUS ASPARTO GLYCINATE; FOLIC ACID; MAGNESIUM OXIDE; PYRIDOXINE HYDROCHLORIDE |
Labeler Name | Avion Pharmaceuticals, LLC |
Pharmaceutical Class | Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inh |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2022-12-31 |
Package
Package Images

NDC 75854-0312-30 (75854031230)
NDC Package Code | 75854-312-30 |
---|---|
Billing NDC | 75854031230 |
Package | 30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-312-30) |
Marketing Start Date | 2014-06-05 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 9.54766 |
Pricing Unit | EA |
Effective Date | 2021-01-30 |
NDC Description | PRENATE DHA SOFTGEL |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 6 |
Classification for Rate Setting | B |
As of Date | 2022-01-12 |
Standard Product Labeling (SPL)/Prescribing Information SPL 8f2eca71-9a82-4a19-9206-36a04b865fe1 Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
INDICATIONS: PRENATE DHA ® is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. PRENATE DHA ® can also be beneficial in improving the nutritional status of women prior to conception.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
SPL UNCLASSIFIED SECTION
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
WARNING
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
HOW SUPPLIED: Bottles of 30 softgels (75854-312-30).
The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Formical ® is a registered trademark of Nephro-Tech 1, LLC, covered by one or more claims of U.S. Patent No. 6,528,542.
Sumalate ® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 5,516,925, 6,716,814, 8,007,846, and 8,425,956.
PRENATE ® is a registered trademark of Avion Pharmaceuticals, LLC. Under license from Avion Pharmaceuticals, LLC.
All rights reserved.
Rev. 0519-02
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
PRENATE DHA
ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, calcium formate, ferrous asparto glycinate, magnesium oxide and doconexent capsule, gelatin coated |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
Labeler - Avion Pharmaceuticals, LLC (040348516) |
Registrant - Avion Pharmaceuticals, LLC (965450542) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Avion Pharmaceuticals, LLC | 040348516 | manufacture(75854-312) |